Dr. Zidoon Nasser, MD

Dr. Nasser practices at Salem Regional Medical Center in Salem, Ohio, part of Salem Regional Medical Center.

Dr. Nasser's NPI, 1366768681, was assigned on April 12, 2010. Dr. Nasser graduated from University of Baghdad College of Medicine in 1994. Dr. Nasser holds Massachusetts license 244808.

Dr. Nasser's primary practice is Salem Regional Medical Center, at 1995 East State Street, Salem, OH 44460 in Columbiana County. The practice phone is (330) 332-7214.

Dr. Nasser's primary practice is Salem Regional Medical Center in Salem, Ohio, part of Salem Regional Medical Center. The medical group on file is Vohra Wound Physicians. Dmand AI also links Dr. Nasser to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nasser practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Nasser's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Nasser is licensed in Massachusetts.

Dmand AI lists chronic embolism thrombosis, chronic skin ulcer, mobility impairment, peripheral vascular disease, pressure ulcers, psoriasis and varicose veins among the conditions Dr. Nasser treats.

CMS data shows 10,616 Medicare services from Dr. Nasser across 19 procedure codes in 2024, for 1,006 Medicare patients. Medicare paid $4,783,867 for them.

CMS counts 1,006 Medicare patients who saw Dr. Nasser in 2024. The largest group is 85 and over, with 367 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nasser's median patient age at 78, with 50% women.

In 2024, Dr. Nasser wrote 133 Medicare Part D claims for 54 patients. 89% of them were for generic drugs. CMS names the drug for 73 of them, across 4 drugs with 11 or more claims each, at $1,617 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Nasser for performance year 2024, reported as part of a group. Dr. Nasser accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nasser as offering telehealth. CMS counts 2,934 procedures of removal of tissue by Dr. Nasser, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Nasser, published from 2008 to 2012. 2010 was the busiest year, with 2. The most frequent topics are Botulinum Toxins, Type A, Bacterial Vaccines and Epithelial Cells. Dr. Nasser's most frequent co-authors are Matthew D. Elias, MD, Ajay Singh and Sunir Joshi, MD.

CMS Open Payments shows 1 general payment to Dr. Nasser from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Smith & Nephew, Inc. paid the most, $91.

Dr. Nasser graduated from University of Baghdad College of Medicine in 1994.

Dr. Nasser is in network with 10 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.